Many science students find themselves in the midst of graduate school or sitting at a lab bench, and realize that they hate lab work Even worse is realizing that they may love science, but science (at least academic science) is not providing many job opportunities these days. What's a poor researcher to do ? This book gives first-hand descriptions of the evolution of a band of hardy scientists out of the lab and into just about every career you can imagine. Researchers from every branch of science found their way into finance, public relations, consulting, business development,...
Many science students find themselves in the midst of graduate school or sitting at a lab bench, and realize that they hate lab work Even worse is re...
"A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers"From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's...
"A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, S...
Die Autorin zeigt, welche gigantischen Profitpotenziale biotechnologischer Fortschritt auf allen Stufen von Geschaft und Investment generiert. Sie gewahrt Einblick in Forschung sowie Produkt-Entwicklung in neuen Geschafts- und Finanzierungsmodellen. Hinweise zu profitabler Anlagestrategie runden das Buch ab."
Die Autorin zeigt, welche gigantischen Profitpotenziale biotechnologischer Fortschritt auf allen Stufen von Geschaft und Investment generiert. Sie gew...